Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
 |
|
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Polygenic burden analysis of longitudinal clusters of psychopathological features in a cross-diagnostic group of individuals with severe mental illness.
Eur. Neuropsychopharmacol. 27, 3, S401-S402 (2017)
Background Bipolar disorder (BD), schizophrenia (SZ) and schizoaffective disorder (SZA) can be disabling disorders associated with severe psychiatric symptomatology. Individual psychopathological features often overlap between these diagnostic groups and their severity can vary widely. More severe psychopathological features are generally associated with a less favorable outcome. Further, all three diseases are common complex genetic disorders with a polygenic genetic architecture in the majority of cases. The inherent heterogeneity with regard to disease severity has posed a significant challenge to both the study of the underlying disease mechanism and the clinical management. Therefore, stratification of cases into more homogeneous subgroups across diagnoses using both longitudinal clusters derived from psychometric data and genetic information could provide a means to identify individuals with higher risk for severe illness, mandating earlier and intensified clinical intervention. Methods Individuals included herein partake in an ongoing multisite cohort study across Germany and Austria (www.kfo241.de; www.PsyCourse.de). Participants were characterized at 4 time points over an 18-months period using a comprehensive phenotyping battery. The subsample used here totals 198 participants (46.9±12.4 yrs; 46% female) with DSM-IV diagnoses of SZ, SZA or BD. Blood DNA samples were genotyped using Illumina’s Infinium PsychArray and imputed using the 1000 genomes. SZ-PRS were calculated using PLINK 1.07. Effect sizes and p-values were determined with the PGC2 SZ summary results as discovery sample. A set of 67 longitudinally measured variables derived from the Positive and Negative Syndrome Scale (PANSS), the Inventory of Depressive Symptoms (IDS) and the Young Mania Rating Scale (YMRS) entered the cluster analyses. Factor analysis for mixed data (FAMD) was applied to compute abstract data dimensions, subsequently used to derive the longitudinal trajectories which then served as inputs for a k-mean clustering for longitudinal data. Identified clusters were employed in a linear regression model as predictive variables for SZ-PRS at 11 thresholds. Results Computed by FAMD, the strongest loadings were observed for PANSS and IDS on the first dimension and for IDS on the second dimension. Two clusters of longitudinal trajectories were identified in these dimensions: (A) individuals with continuously low scores on both PANSS and IDS (70.7%) and (B) individuals with consistently high scores on both PANSS and IDS (29.3%). Clusters differed significantly with regard to Global Assessment of Functioning (GAF; higher in (A); FDR-adjusted p-value=2.23x10-10), while there were no significant differences regarding sex, age, diagnoses, center, age at onset, family history or duration of illness. Cluster membership was not significantly associated with the SZ-PRS in either cluster. Discussion Although the results are preliminary and have to be interpreted with caution, the approach of longitudinal clustering to identify cross-diagnostic homogeneous subgroups of individuals appears to be feasible. The fact that more severe psychopathological features were not associated with increased genetic risk burden will also be interesting to explore further.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
ISSN (print) / ISBN
0924-977X
e-ISSN
1873-7862
Zeitschrift
European Neuropsychopharmacology : ENP
Quellenangaben
Band: 27,
Seiten: S401-S402,
Supplement: 3
Verlag
Elsevier
Verlagsort
Amsterdam
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Computational Biology (ICB)